The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Expression of Concern: Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro
Open accessAbstract
The aggregation of α‐synuclein (αS) in the brain has been implicated as a critical step in the development of Lewy body diseases (LBD) and multiple system atrophy (MSA). Various antioxidants not only inhibit the formation of β‐amyloid fibrils (fAβ), but also destabilize preformed fAb in vitro. Using fluorescence spectroscopy with thioflavin S and electron microscopy, here we examined the effects of the antioxidants nordihydroguaiaretic acid, curcumin, rosmarinic acid, ferulic acid, wine‐related polyphenols [tannic acid, myricetin, kaempferol (+)‐catechin and (–)‐epicatechin], docosahexaenoic acid, eicosapentaenoic acid, rifampicin and tetracycline on the formation of αS fibrils (fαS) and on preformed fαS. All molecules, except for docosahexaenoic acid and eicosapentaenoic acid, dose‐dependently inhibited the formation of fαS. Moreover, these molecules dose‐dependently destabilized preformed fαS. The overall activity of the molecules examined was in the order of: tannic acid = nordihydroguaiaretic acid = curcumin = rosmarinic acid = myricetin > kaempferol = ferulic acid > (+)‐catechin = (–)‐epicatechin > rifampicin = tetracycline. These compounds with anti‐fibrillogenic as well as antioxidant activities could be key molecules for the development of preventives and therapeutics for LBD and MSA as well as Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 3×
“Pathologically, Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons from the substantia nigra region of the brain, with some surviving nigral dopaminergic neurons containing cytosolic filamentous inclusions known as Lewy bodies (LBs) and Lewy neurites (LNs) (Forno 1996). aS is a m…”
BackgroundMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm
Wright, P. E., & Dyson, H. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3110 · Cited by 2,968
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Intrinsically disordered protein
Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., et al. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00138-8 · Cited by 2,272
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y.-J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., & Lin, J.-K. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,705
Intrinsically Disordered Proteins
Uversky, V. N. (2013) · Brenner's Encyclopedia of Genetics · doi:10.1016/b978-0-12-374984-0.01698-3 · Cited by 1,637
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,523
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Self-citationPetersen, M. (2003) · Phytochemistry · doi:10.1016/s0031-9422(02)00513-7 · Cited by 1,234
Nitric Oxide Scavenging by Curcuminoids
Sreejayan, & Rao, M. N. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,135
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Antioxidant potential of ferulic acid
Graf, E. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90184-i · Cited by 1,115
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices
Hertog, M. G. L., Hollman, P. C. H., & van de Putte, B. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00032a015 · Cited by 895
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748
α-Synuclein Fibrillogenesis Is Nucleation-dependent
Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 720
Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681
Self-citationSpira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00490.x · Cited by 567
Kinetic theory of fibrillogenesis of amyloid β-protein
Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529
Asanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 516
The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils
Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., & Fink, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403129200 · Cited by 473
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents
Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.467s · Cited by 441
Volles, M. J., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi030086j · Cited by 433
Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation
Soto, C., Kindy, M. S., Baumann, M., & Frangione, B. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1413 · Cited by 431
Butterfield, D. A., & Kanski, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 419
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals
Zhao, B., Li, X., He, R., Cheng, S., & Wenjuan, X. (1989) · Cell Biophysics · doi:10.1007/bf02797132 · Cited by 322
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302
Yazawa, I., Giasson, B. I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.032 · Cited by 301
Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., & Endo, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6839 · Cited by 295
[20] Kinetic analysis of amyloid fibril formation
(1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09022-9 · Cited by 287
Giasson, B. I., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 279
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.008 · Cited by 265
Self-citationAnti‐amyloidogenic activity of tetracyclines: studies in vitro
Forloni, G., Colombo, L., Girola, L., Tagliavini, F., & Salmona, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02380-2 · Cited by 242
Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic
Iwai, A., Yoshimoto, M., Masliah, E., & Saitoh, T. (1995) · Biochemistry · doi:10.1021/bi00032a006 · Cited by 238
Virgili, M., & Contestabile, A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00820-x · Cited by 233
Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Li, J., Zhu, M., Rajamani, S., Uversky, V. N., & Fink, A. L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.025 · Cited by 218
Irizarry, M. C., Kim, T.-W., MCNamara, M., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205
Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202
Strategy and planning for chemopreventive drug development: Clinical development plans II
Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630705 · Cited by 196
Effect of Antibiotics on the Generation of Reactive Oxygen Species
Miyachi, Y., Yoshioka, A., Imamura, S., & Niwa, Y. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285793 · Cited by 188
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Ferulic acid destabilizes preformed β-amyloid fibrils in vitro
Ono, K., Hirohata, M., & Yamada, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.148 · Cited by 172
Self-citationMandel, S., Maor, G., & Youdim, M. B. H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:401 · Cited by 171
Shutenko, Z., Henry, Y., Pinard, E., Seylaz, J., Potier, P., Berthet, F., Girard, P., & Sercombe, R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00296-2 · Cited by 161
Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro
Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., & Endo, N. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2428 · Cited by 158
Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses
Trojanowski, J. Q., & LEE, V. M. ‐. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07468.x · Cited by 150
Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone
Celotti, E., Ferrarini, R., Zironi, R., & Conte, L. S. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(95)00962-0 · Cited by 145
Spencer, J. P. E., Jenner, A. M., Butler, J., Aruoma, O. I., Dexter, D. T., Jenner, P. G., & Halliwell, B. B. (1996) · Free Radical Research · doi:10.3109/10715769609088005 · Cited by 144
Diet, body size and micronutrient status in Parkinson's disease.
Abbott, R. A., Cox, M., Markus, H. S., & Tomkins, A. M. (1992) · PubMed · Cited by 139
Inanami, O., Watanabe, Y., Syuto, B., Nakano, M., Tsuji, M., & Kuwabara, M. (1998) · Free Radical Research · doi:10.1080/10715769800300401 · Cited by 135
Nie, G., Cao, Y., & Zhao, B. (2002) · Redox Report · doi:10.1179/135100002125000424 · Cited by 124
Xu, Y. X., Pindolia, K. R., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (1997) · PubMed · Cited by 123
Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Yoshiike, Y., Takashima, A., Yamada, M., & Naiki, H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00904.x · Cited by 122
Self-citationNaiki, H., Gejyo, F., & Nakakuki, K. (1997) · Biochemistry · doi:10.1021/bi9624705 · Cited by 120
Naiki, H., Hasegawa, K., Yamaguchi, I., Nakamura, H., Gejyo, F., & Nakakuki, K. (1998) · Biochemistry · doi:10.1021/bi980550y · Cited by 119
Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro
Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01417-8 · Cited by 116
Self-citationParnham, M. J., & Kesselring, K. (1985) · Drugs of the Future · doi:10.1358/dof.1985.010.09.71743 · Cited by 103
Multiple Antioxidants in the Prevention and Treatment of Parkinson’s Disease
Prasad, K. N., Cole, W. C., & Kumar, B. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718878 · Cited by 102
Nicotine and amyloid formation
Zeng, H., Zhang, Y., Peng, L., Shao, H., Menon, N. K., Yang, J., Salomon, A. R., Freidland, R. P., & Zagorski, M. G. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01111-2 · Cited by 81
Luo, J., Chuang, T., Cheung, J., Quan, J., Tsai, J., Sullivan, C. S., Hector, R. F., Reed, M. J., Meszaros, K., King, S. R., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00139-3 · Cited by 81
Neuroprotection by dopamine agonists
Lange, K. W., Rausch, W., Gsell, W., Naumann, M., Oestreicher, E. M., & Riederer, P. F. (1994) · PubMed · doi:10.5283/epub.25419 · Cited by 63
Cited by
Myricetin: A Dietary Molecule with Diverse Biological Activities
Semwal, D., Semwal, R., Combrinck, S., & Viljoen, A. (2016) · Nutrients · doi:10.3390/nu8020090 · Cited by 707
Hudson, S. A., Ecroyd, H., Kee, T. W., & Carver, J. A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07307.x · Cited by 610
Neuroprotective effects of curcumin
Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516
Wu, Y., Wu, Z., Butko, P., Christen, Y., Lambert, M. P., Klein, W. L., Link, C. D., & Luo, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3448-06.2006 · Cited by 406
Natural products as a source of Alzheimer's drug leads
Williams, P., Sorribas, A., & Howes, M.-J. R. (2011) · Nat. Prod. Rep. · doi:10.1039/c0np00027b · Cited by 404
Metadata
- Authors
- Ono, K., & Yamada, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-08
- Volume
- 97
- Issue
- 1
- Pages
- 105-115
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2058233568
- Cited by
- 320
- References
- 78
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.